Metastasis has been one of the major reasons for cancer-related mortality, with multiple genes and pathways being involved in this complex process. Given the molecular variations underlying metastasis of hepatocellular carcinoma (HCC) remains largely unknown; in our previous work, we found copying number of protocadherin-17 (PCDH-17) was significantly deleted in HCC tissues that occurred to metastasize compared with that in the primary HCC without metastasis. Therefore, we hypothesized that PCDH-17 may suppress the metastasis of HCC. There has been, however, no relevant literature available regarding PCDH-17 in HCC. In the present study, we have immunohistochemically detected and clinicopathologically analyzed the expression of PCDH-17 in vivo in clinical tissues; besides, we have explored the role of PCDH-17 ex vivo using a panel of HCC cell lines. It was discovered that PCDH-17 expression was clinically correlated with overall prognosis as well as metastasis in vivo and that PCDH-17 inhibited metastasis via EGFR/MEK/ERK signaling pathway ex vivo. Together, our results obtained both in vivo and ex vivo suggested that activation of EGFR/MEK/ERK signaling pathway through PCDH-17 promotes metastasis in HCC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13277-015-3970-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells.
Anticancer Res
December 2024
Department of Psychiatry, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan, R.O.C.;
Background/aim: Hepatocellular carcinoma (HCC) is a primary liver cancer with high mortality rates worldwide, necessitating effective therapeutic strategies. Imipramine demonstrates the potential to augment standard treatments of different cancers, highlighting its therapeutic promise in oncology. This study aimed to investigate the potential regulation of imipramine on HCC.
View Article and Find Full Text PDFmiR-155 promotes m6A modification of SOX2 mRNA through targeted regulation of HIF-1α and delays wound healing in diabetic foot ulcer in vitro models.
J Diabetes Investig
January 2025
Department of Endocrinology, The Third People's Hospital of Yunnan Province, Kunming, China.
Article Synopsis
- The study focuses on the connection between miR-155 and SOX2 in the context of diabetic foot ulcers (DFU) and their impact on wound healing mechanisms.
- Using human keratinocyte models, researchers explored how inhibiting miR-155 affects cell proliferation, apoptosis, and migration related to wound healing.
- Findings revealed that inhibiting miR-155 boosts HIF-1α levels, leading to increased SOX2 expression and activation of the EGFR/MEK/ERK signaling pathway, which enhances wound healing in DFU models.
Unveiling the regulatory mechanism of nimotuzumab on PD-L1 expression in head and neck squamous cell carcinoma patients: Implications for enhanced anticancer treatment strategies.
Cell Signal
September 2024
School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, PR China; Department of National Institute for Drug Clinical Trial, Affiliated Beijing Tongren Hospital of Capital Medical University, Beijing 100005, PR China. Electronic address:
Article Synopsis
- * In lab tests, nimotuzumab was shown to reduce PD-L1 levels in HNSCC cells by blocking the IFN-γ-induced signaling pathway, specifically the EGFR/MEK/ERK pathway.
- * In mouse models, treatment with nimotuzumab led to lower PD-L1 levels and enhanced tumor sensitivity to chemotherapy, showing its potential to improve the effectiveness of cancer treatments in HNSCC patients.
Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/ERK Signaling Pathway.
Discov Med
April 2024
Department of Oncology, Qingdao Municipal Hospital, Shandong University, 266012 Qingdao, Shandong, China.
Background: Over 80% of lung cancer cases constitute non-small cell lung cancer (NSCLC), making it the most prevalent type of lung cancer globally and the leading cause of cancer-related deaths. The treatment of NSCLC patients with gefitinib has demonstrated promising initial efficacy. However, the underlying mechanism remains unclear.
View Article and Find Full Text PDFThe Treatment of Tubal Inflammatory Infertility using Yinjia Tablets through EGFR/MEK/ERK Signaling Pathway based on Network Pharmacology.
Curr Pharm Biotechnol
April 2024
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Article Synopsis
- Salpingitis obstructive infertility (SOI) is a significant health issue for women, caused by tubal blockage and inflammation, affecting both physical and mental well-being.
- This study aimed to investigate the effects of Yinjia tablets (YJP) on tubal inflammation using network pharmacology and a rat model to assess their therapeutic potential.
- Results indicated that YJP targets key proteins related to inflammation, showing improvements in inflammatory markers and overall tubal health in the treated rats.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!